Production Cost Report
rifampicin-e11a
amoxicillin-e11a,pyrantel-pamoate-e11a,bronopol-e11a
Rifampicin
Rifampicin
Rifampin
Rifampicin (a.k.a. Rifampin) iis a macrocyclic antibiotic with strong activity against gram-positive bacteria and gram-negative cocci, mycobacteria, commonly used in combination with other agents as therapy of tuberculosis, leprosy, and legionella. Rifampicin is produced by the microorganism Streptomyces mediterranei.
The uses and applications of Rifampicin may vary according to its specification. The main forms of Rifampicin are molecular biology grade; and purity greater than 97%.

Rifampicin Cost of Production | Q4 2023

Updated Reports Examining Rifampicin Manufacturing Costs

Intratec offers professional, easy-to-understand Commodity Cost of Production reports analyzing the costs of Rifampicin manufacturing processes. Each report describes an industrial plant based on a specific Rifampicin process. The report also presents an independent analysis of the costs of Rifampicin production, encompassing plant capital costs (capex) and plant operating costs (opex). All reports are based on the most recent economic data available (Q4 2023).

Rifampicin Production

This report presents the economics of Rifampicin production from mixed carbon sources (peanut meal, soybean flour, glucose, and starch) in the United States, via a typical fermentation process of Nocardi mediterranei. The fermentation produces rifamycin B, which is further processed in many steps until Rifampicin is obtained.

Details: 0.10 kta United States-based plant   |   Q4 2023   |   107 pages   From $1,999 USD

The cost analyses presented in the report Rifampicin E11A target a 0.10 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Could Not Find the Production Cost Report you Need?

If none of the Rifampicin reports listed above fits your needs, you can request a bespoke report examining the process you are interested in! You will have a report tailored to your needs, in which you defined production process, industrial plant capacity and location!

Details: Customer-defined Plant Location & Capacity  |   Q4 2023 From $2,900 USD

Customers Who Bought This Report Also Bought

Amoxicillin Production

This report presents the economics of Amoxicillin Trihydrate production from D(-)p-hydroxyphenylglycine and 6-APA in the United States. The process examined is a conventional chemical synthesis (via the Dane salt route).

Details: 0.40 kta United States-based plant   |   Q4 2023   |   108 pages From $1,999 USD

The cost analyses presented in the report Amoxicillin E11A target a 0.40 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Bronopol Production

This report presents the economics of a typical Bronopol production process from sodium hydroxide, calcium chloride, nitromethane, and liquid bromine in the United States.

Details: 100 kta United States-based plant   |   Q4 2023   |   107 pages From $1,999 USD

The cost analyses presented in the report Bronopol E11A target a 100 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Pyrantel Pamoate Production

This report presents the economics of Pyrantel Pamoate production from 2-thiophene aldehyde in the United States. 3-Methylamine propylamine is first sent to a cyclization step before it is reacted with 2-thiophene aldehyde. Ethanol and citric acid are added to the reaction product, followed by the addition of a pamoic acid solution for recrystallization, obtaining pyrantel pamoate.

Details: 0.10 kta United States-based plant   |   Q4 2023   |   107 pages From $1,999 USD

The cost analyses presented in the report Pyrantel Pamoate E11A target a 0.10 kta (kilometric tons per annum) United States-based plant. For those interested in cost analyses considering other plant capacities and/or locations, Intratec offers a customized analysis as an optional feature.

Use our Reports as

Feasibility Studies

Techno-economic Evaluations

Investment Analyses

Multi-regional Cost Analyses

Trusted By

BASF
Monsanto
Linde

About Rifampicin. Rifampicin (a.k.a. Rifampin) iis a macrocyclic antibiotic with strong activity against gram-positive bacteria and gram-negative cocci, mycobacteria, commonly used in combination with other agents as therapy of tuberculosis, leprosy, and legionella. Rifampicin is produced by the microorganism Streptomyces mediterranei.

Rifampicin Uses. The uses and applications of Rifampicin may vary according to its specification. The main forms of Rifampicin are molecular biology grade; and purity greater than 97%.

Intratec Methodology. Intratec distilled its expertise, gained from more than a decade of supporting companies worldwide in the analysis of commodities markets and process economics, and developed a consistent report development methodology.

The methodology ensures a holistic, coherent, and consistent techno-economic evaluation, guiding the development of a report that allows readers to fully understand a specific process technology for the production of a commodity. In addition to being based on a common methodology, all Intratec reports that approach industrial processes have a common structure, i.e., indexes, tables and charts share similar standards. This ensures that Intratec’s readers know upfront what they will get and, more than that, will be able to compare technologies addressed in different reports.

Our methodology is continuously tested and proven by the many corporations involved with the commodities sector, R&D centers, EPC companies, financial institutions and government agencies that rely on our reports.

Check Intratec Methodology to better understand how Intratec develops Commodity Cost of Production Reports.